Molecular Partners Ag (MOLN) Liabilities and Shareholders Equity (2020 - 2025)
Molecular Partners Ag (MOLN) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $127.8 million as the latest value for Q4 2025.
- Quarterly Liabilities and Shareholders Equity fell 29.4% to $127.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $804.6 million through Dec 2025, down 6.89% year-over-year, with the annual reading at $123.2 million for FY2025, 31.66% down from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 was $127.8 million at Molecular Partners Ag, down from $181.0 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $272.2 million in Q4 2022, with the low at $127.8 million in Q4 2025.
- Average Liabilities and Shareholders Equity over 5 years is $198.4 million, with a median of $187.3 million recorded in 2021.
- The sharpest move saw Liabilities and Shareholders Equity skyrocketed 45.38% in 2022, then decreased 29.4% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $187.3 million in 2021, then surged by 45.38% to $272.2 million in 2022, then dropped by 17.86% to $223.6 million in 2023, then dropped by 19.07% to $181.0 million in 2024, then decreased by 29.4% to $127.8 million in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $127.8 million, $181.0 million, and $223.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.